Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma.

Enkelejda LamajErwin VuJanita E van TimmerenChiara LeonardiLouise MarcIzabela PytkoMatthias GuckenbergerPanagiotis Balermpas

Published in: Radiation oncology (London, England) (2021)

A significantly improved cochlea sparing beyond current QUANTEC constraints is feasible without compromising the PTV dose coverage in nasopharyngeal carcinoma patients treated with VMAT. As there appears to be no threshold for hearing toxicity after CRT, this should be considered for future treatment planning.

Keyphrases

robot assisted
early stage
current status
radiation therapy
oxidative stress
locally advanced
radiation induced
affordable care act
healthcare
left ventricular